# A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

> **NCT06112678** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 63 (actual)

## Conditions studied

- Hypertension
- Dyslipidemias

## Interventions

- **DRUG:** CKD-348(6)
- **DRUG:** CKD-828, D097, D337

## Key facts

- **NCT ID:** NCT06112678
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-04
- **Primary completion:** 2024-02-19
- **Final completion:** 2024-03-18
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06112678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06112678, "A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06112678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*